Macpod 200 Tablet contains Cefpodoxime Proxetil 200mg, a third-generation oral cephalosporin antibiotic with broad-spectrum activity against various gram-positive and gram-negative bacteria. It is indicated for the treatment of respiratory tract infections, including acute exacerbations of chronic bronchitis, community-acquired pneumonia, pharyngitis, and tonsillitis. Additionally, it is effective in managing uncomplicated urinary tract infections, skin and soft tissue infections, and gonorrhea. Cefpodoxime Proxetil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The prodrug form ensures enhanced oral bioavailability, with rapid conversion to the active cefpodoxime after absorption. Macpod 200 is generally well-tolerated; common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, can occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, renal function, and patient age. It is essential to complete the full prescribed course to prevent resistance development. Macpod 200 should be used under medical supervision, with caution advised in patients with hepatic or renal impairment. This antibiotic offers an effective treatment option for a wide range of bacterial infections.